Endovia Health Sciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| EDVA | ARTL | 18H0.F | CANF | SPRC | EOCN | |
|---|---|---|---|---|---|---|
| Market cap | 2.11M | 1.24M | 5.11M | 5.06M | 297.81K | 2.96M |
| P/E (TTM) | — | — | — | — | 0.0 | — |
| Forward P/E | — | -2.6 | — | -1.8 | — | — |
| Price/book | 0.0 | 0.2 | -1.1 | 0.7 | 0.1 | 0.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −96.39% | −95.46% | −25.00% | −80.12% | −97.87% | −71.92% |
| Today | +3.23% | −5.42% | −23.81% | +3.02% | −14.48% | −1.42% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All EDVA news ›How to Install End-4 (illogical-impulse) on NixOS
Combining End-4’s modern Hyprland interface with the atomic stability of NixOS gives you the ultimate desktop setup. Here is the step-by-step walkthrough to install End4 dotfiles on NixOS cleanly. In this guide, we will cover how to: By…
Endologix Debuts New Corporate Brand
New identity reflects a broader commitment to physicians treating vascular disease and to the patients who depend on sustained blood flow. Oct. 5, 2026 – Endologix Holdings, LLC has announced Rhevera Medical as its new corporate brand. The…
Endovia Health Sciences Announces FDA Minor Use Determination for CannEpil® in Dogs With Bone Cancer Pain
Endovia Health announces FDA classification of CannEpil® for bone cancer pain management in dogs, pursuing conditional approval. CannEpil® is an investigational oral solution for controlling pain associated with bone cancer in dogs. The…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- dicardiology.com1
- quiverquant.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.